These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 30196142
1. Loading studies of the anticancer drug camptothecin into dual stimuli-sensitive nanoparticles. Stability scrutiny. Iglesias N, Galbis E, Díaz-Blanco MJ, de-Paz MV, Galbis JA. Int J Pharm; 2018 Oct 25; 550(1-2):429-438. PubMed ID: 30196142 [Abstract] [Full Text] [Related]
2. High Drug Loading, Reversible Disulfide Core-Cross-Linked Multifunctional Micelles for Triggered Release of Camptothecin. Ling L, Ismail M, Du Y, Xia Q, He W, Yao C, Li X. Mol Pharm; 2018 Dec 03; 15(12):5479-5492. PubMed ID: 30376635 [Abstract] [Full Text] [Related]
3. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC. J Control Release; 2008 May 08; 127(3):208-18. PubMed ID: 18336946 [Abstract] [Full Text] [Related]
4. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency. Li J, Hu ZE, Yang XL, Wu WX, Xing X, Gu B, Liu YH, Wang N, Yu XQ. Biomater Sci; 2019 Aug 01; 7(8):3277-3286. PubMed ID: 31180396 [Abstract] [Full Text] [Related]
5. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles. Wang Z, Li Q, Zhao X, Sun B, Zhu Q, Gao W, Hua C. Int J Pharm; 2014 Apr 25; 465(1-2):360-7. PubMed ID: 24530520 [Abstract] [Full Text] [Related]
6. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells. Aluri R, Jayakannan M. Biomacromolecules; 2017 Jan 09; 18(1):189-200. PubMed ID: 28064504 [Abstract] [Full Text] [Related]
7. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy. He W, Du Y, Zhou W, Wang T, Li M, Li X. Eur J Pharm Sci; 2020 Jul 01; 150():105340. PubMed ID: 32371069 [Abstract] [Full Text] [Related]
8. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery. Cirpanli Y, Bilensoy E, Lale Doğan A, Caliş S. Eur J Pharm Biopharm; 2009 Sep 01; 73(1):82-9. PubMed ID: 19442723 [Abstract] [Full Text] [Related]
9. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Koo OM, Rubinstein I, Onyuksel H. Nanomedicine; 2005 Mar 01; 1(1):77-84. PubMed ID: 17292061 [Abstract] [Full Text] [Related]
10. SN-38 loading capacity of hydrophobic polymer blend nanoparticles: formulation, optimization and efficacy evaluation. Dimchevska S, Geskovski N, Petruševski G, Chacorovska M, Popeski-Dimovski R, Ugarkovic S, Goracinova K. Drug Dev Ind Pharm; 2017 Mar 01; 43(3):502-510. PubMed ID: 27910713 [Abstract] [Full Text] [Related]
11. Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing. Ao M, Yu F, Li Y, Zhong M, Tang Y, Yang H, Wu X, Zhuang Y, Wang H, Sun X, Hong X, Chen XD. J Nanobiotechnology; 2021 Oct 30; 19(1):350. PubMed ID: 34717646 [Abstract] [Full Text] [Related]
16. Multistimuli-Responsive Amphiphilic Poly(ester-urethane) Nanoassemblies Based on l-Tyrosine for Intracellular Drug Delivery to Cancer Cells. Aluri R, Saxena S, Joshi DC, Jayakannan M. Biomacromolecules; 2018 Jun 11; 19(6):2166-2181. PubMed ID: 29664622 [Abstract] [Full Text] [Related]
19. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles. Yang L, Cui F, Cun D, Tao A, Shi K, Lin W. Int J Pharm; 2007 Aug 01; 340(1-2):163-72. PubMed ID: 17482779 [Abstract] [Full Text] [Related]